NEW YORK, NY — As the sun sets on October 13, 2026, a synchronized wave of teal, green, and pink light will sweep across the globe. From the towering heights of One World Trade Center in Manhattan to the mist-shrouded roar of Niagara Falls, and across the oceans to the Mactan-Cebu Airport in the Philippines, more than 325 iconic landmarks will illuminate in a unified display of solidarity. This is not merely a celebration; it is a global mobilization known as #LightUpMBC.
Organized by METAvivor Research and Support, the campaign marks National Metastatic Breast Cancer (MBC) Awareness Day. Its goal is to pierce through the traditional "pink-ribbon" narrative of Breast Cancer Awareness Month to highlight a stark and often overlooked reality: metastatic breast cancer—Stage 4—remains an incurable disease. On this day, the #LightUpMBC movement aims to turn symbolic light into tangible action, raising millions of dollars to fund the research necessary to transform a terminal diagnosis into a manageable, chronic condition.
Main Facts: The Scope of a Global Illumination
The 2026 #LightUpMBC campaign represents the largest coordinated effort in the history of metastatic breast cancer advocacy. This year, the initiative has secured the participation of landmarks in all 50 U.S. states, spanning 195 cities and 20 countries. The choice of colors—teal, green, and pink—is intentional and symbolic. Teal represents healing and spirituality, green symbolizes the triumph of spring over winter (life over death), and pink signifies the breast cancer origin of the disease.
The centerpiece of the day is the #LightUpMBC Live broadcast, a free global streaming event scheduled for 8 p.m. ET / 5 p.m. PT. Hosted by creator and 11-year MBC survivor Tami Eagle Bowling alongside Broadway star Kara Lindsay, the program serves as a bridge between the clinical world of oncology and the deeply personal experiences of patients. The broadcast will feature a high-profile lineup of performers, including two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood, alongside scientific experts who will provide updates on the latest breakthroughs in Stage 4 research.
Crucially, METAvivor remains one of the few organizations where 100% of net proceeds from the campaign go directly to MBC research grants. In a landscape where the majority of breast cancer funding is directed toward early detection and prevention, METAvivor focuses exclusively on the stage of the disease that is responsible for nearly all breast cancer-related deaths.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal promise and a singular vision. In 2017, the campaign began with the illumination of a single structure: the Memorial Bridge in Portsmouth, New Hampshire. It was inspired by Jessica Moore, a young woman diagnosed with metastatic breast cancer who passed away at the age of 36.
Jessica’s wish was modest—she wanted to see one local landmark lit in the MBC awareness colors to help her community understand that her "type" of breast cancer was different. Following her passing, her best friend, Laura Inahara, took up the mantle. What began as a local tribute quickly resonated with a community of patients and caregivers who felt sidelined by traditional "pink" campaigns that focused heavily on "survivorship" and "finishing treatment"—concepts that do not apply to those with Stage 4 disease.
By 2020, despite the challenges of a global pandemic, the movement moved online with its first virtual broadcast, allowing patients who were immunocompromised or too ill to travel to participate from their homes. Over the last nine years, the campaign has evolved into a powerhouse of fundraising, having raised over $2.7 million for critical research prior to the 2026 event. Today, the 325+ landmarks involved represent a massive scaling of Jessica Moore’s original dream, proving that a localized spark of advocacy can indeed ignite a global movement.
Supporting Data: The Stark Reality of Stage 4
To understand the urgency behind #LightUpMBC, one must look at the data surrounding metastatic breast cancer. MBC occurs when breast cancer cells break away from the original tumor and travel through the lymphatic system or bloodstream to distant parts of the body. The most common sites of metastasis are the bones, liver, lungs, and brain.
The statistics for 2026 remain sobering:
- Mortality Rates: An estimated 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to approximately 117 deaths every single day.
- The Funding Gap: Historically, while billions of dollars are raised for breast cancer annually, it is estimated that only 2% to 5% of overall breast cancer research funding is dedicated to the metastatic stage. This is a significant point of contention for advocates, as 100% of breast cancer deaths are caused by metastasis.
- The "De Novo" Factor: While many associate Stage 4 with a recurrence of an earlier cancer, a significant portion of patients are diagnosed "de novo," meaning the cancer has already spread by the time it is first discovered.
- The Myth of the "Cure": For those in the MBC community, the term "No Evidence of Disease" (NED) is a temporary victory, not a permanent cure. Because the cancer is systemic, it often develops resistance to current therapies, requiring a perpetual cycle of new treatments, scans, and side effects.
METAvivor’s research funding is designed to address this "revolving door" of treatment. By utilizing a rigorous peer-review process that includes both scientific experts and patient advocates, the organization ensures that the projects funded are those with the highest potential to extend life and improve the quality of that life.
Official Responses: Voices of Leadership and Advocacy
The leadership of METAvivor emphasizes that while the lights are beautiful, the mission is scientific. Dr. Kelly Shanahan, a physician and the Board President of METAvivor, offers a unique perspective as both a medical professional and a patient.
“When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan remarked. “My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
Laura Inahara, the founder of the campaign, reflects on the legacy of the woman who started it all. “Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
Tami Eagle Bowling, the campaign director and host of the live stream, highlights the importance of the broadcast in humanizing the statistics. By featuring patient stories shared live from the foot of illuminated landmarks, the program aims to give a face to the 117 people lost every day, transforming them from data points into daughters, mothers, fathers, and friends.
Implications: Changing the Future of Oncology
The implications of the #LightUpMBC campaign extend far beyond a single night in October. By successfully raising millions of dollars specifically for Stage 4 research, METAvivor is shifting the needle of oncological science. The goal is no longer just "awareness," but the actual transformation of a terminal illness.
1. From Terminal to Chronic
The ultimate aim of METAvivor-funded research is to reach a point where MBC can be managed much like HIV or Type 1 Diabetes. Through targeted therapies and immunotherapy, researchers hope to keep the cancer "asleep" for decades, allowing patients to live full lives. The 2026 campaign is a critical financial engine for this transition.
2. Challenging the "Pink Ribbon" Narrative
The campaign serves as a necessary critique of "pink-washing." By reclaiming October 13, the MBC community is demanding that the conversation around breast cancer include the reality of death and the necessity of treatment for those who cannot be "cured" by early detection. This has led to a more nuanced public understanding of the disease.
3. Empowerment through Advocacy
The #LightUpMBC movement provides a platform for patients to become advocates. In participating in the landmark lightings and the social media campaign, patients find a sense of agency that is often lost in the wake of a Stage 4 diagnosis. The visibility of 325 landmarks tells the patient that they are not invisible and that the world is finally paying attention to the specific needs of the metastatic community.
4. Global Scientific Collaboration
The funds raised on October 13 will be distributed to researchers worldwide. By bypassing traditional bureaucratic funding hurdles and focusing on high-risk, high-reward Stage 4 projects, METAvivor is accelerating the pace of discovery.
As the lights fade on the morning of October 14, the work will continue. The photographs shared across social media using #LightUpMBC and #METAvivor will remain as a digital testament to a community that refuses to be overshadowed. With 117 lives lost every day, the urgency is clear: the light must stay on until a cure is found.
For more information, to view participating landmarks, or to donate to research, visit www.lightupmbc.org.
About the Author
